Kymos Group SL is a GLP/GMP-certified, GCP-compliant Contract Research Organisation (CRO) based in Barcelona, Spain. Specialising in bioanalysis and Chemistry, Manufacturing and Controls (CMC), Kymos offers a comprehensive range of services to the pharmaceutical industry, including bioanalysis for preclinical and clinical trials involving small molecules, biologics, and oligonucleotides. The company is also experienced in pharmacokinetics (PK), full bioequivalence studies, and biowaivers for topical products. Kymos has been inspected by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), underscoring its commitment to high-quality standards and regulatory compliance.

Services include:
– Contract Research
– Laboratory and Analytical Services
– Bioanalysis for small molecules, biologics, and oligonucleotides
– Preclinical and clinical trial support
– Pharmacokinetics (PK) studies
– Full bioequivalence studies
– Biowaivers for topical products
– CMC services for method development
– Batch testing and release
– Stability testing
– Biosimilars comparability
– Characterization of innovator products

Kymos Group SL has extensive experience collaborating with biopharma clients worldwide, ensuring the delivery of high-quality analytical and contractual research services. For more information, visit kymos.es.